TNF Pharmaceuticals Inc (NASDAQ:TNFA) has a beta value of 2.45 and has seen 0.47 million shares traded in the recent trading session. The company, currently valued at $1.02M, closed the recent trade at $0.37 per share which meant it gained $0.02 on the day or 5.89% during that session. The TNFA stock price is -845.95% off its 52-week high price of $3.50 and 13.51% above the 52-week low of $0.32. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.19 million shares traded. The 3-month trading volume is 527.83K shares.
TNF Pharmaceuticals Inc (NASDAQ:TNFA) trade information
Sporting 5.89% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the TNFA stock price touched $0.37 or saw a rise of 3.9%. Year-to-date, TNF Pharmaceuticals Inc shares have moved -67.77%, while the 5-day performance has seen it change 4.20%. Over the past 30 days, the shares of TNF Pharmaceuticals Inc (NASDAQ:TNFA) have changed -5.72%. Short interest in the company has seen 0.78 million shares shorted with days to cover at 1.18.
TNF Pharmaceuticals Inc (TNFA) estimates and forecasts
The company’s shares have lost -75.78% over the past 6 months. If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 67.29% over the past 5 years.
TNFA Dividends
TNF Pharmaceuticals Inc is expected to release its next earnings report in May this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
TNF Pharmaceuticals Inc (NASDAQ:TNFA)’s Major holders
Insiders own 0.59% of the company shares, while shares held by institutions stand at 15.10% with a share float percentage of 15.19%. Investors are also buoyed by the number of investors in a company, with TNF Pharmaceuticals Inc having a total of 26.0 institutions that hold shares in the company.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund. As of Dec 31, 2024, the former fund manager holds about 0.50% shares in the company for having 13.69 shares of worth $5110.0 while later fund manager owns 11.21 shares of worth $4185.0 as of Jan 31, 2025, which makes it owner of about 0.41% of company’s outstanding stock.
